Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer

• Publication date

  2006-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.22116PMID 16900523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changing nature of high risk patients undergoing radical prostatectomy.

  2007cited by this paper
• Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease.

  2005cited by this paper
• Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta").

  2005cited by this paper
• Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

  2005cited by this paper
• 20-year outcomes following conservative management of clinically localized prostate cancer.

  2005cited by this paper
• Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy

  2005cited by this paper
• The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy.

  2005cited by this paper
• Achieving optimal outcomes after radical prostatectomy.

  2005cited by this paper
• Impact of surgical delay on long-term cancer control for clinically localized prostate cancer.

  2004cited by this paper
• Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease.

  2004cited by this paper
• Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.

  2003cited by this paper
• Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.

  2003cited by this paper
• Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8

  2003cited by this paper
• Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

  2003cited by this paper
• Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

  2003cited by this paper
• Management of high-risk populations with locally advanced prostate cancer.

  2003cited by this paper
• Role of Radical Retropubic Prostatectomy in Patients with Locally Advanced Prostate Cancer: The Influence of Gleason Score 8–10

  2003cited by this paper
• Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone.

  2002cited by this paper
• Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma.

  2002cited by this paper
• Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables.

  2002cited by this paper
• Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

  2002cited by this paper
• Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

  2001cited by this paper
• Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.

  2001cited by this paper
• Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer

  2000cited by this paper
• Role of radical prostatectomy in patients with prostate cancer of high Gleason score

  1999cited by this paper
• Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

  1998cited by this paper
• Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis.

  1997cited by this paper
• Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate.

  1997cited by this paper
• [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].

  1995cited by this paper
• The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy.

  1994cited by this paper
• Radical prostatectomy for high grade disease: a reevaluation 1994.

  1994cited by this paper
• Correlation of pathologic findings with progression after radical retropubic prostatectomy

  1993cited by this paper
• Radical retropubic prostatectomy and pelvic lymphadenectomy for high‐stage cancer of the prostate

  1981cited by this paper

• Contemporary management of locally advanced prostate cancer: a narrative review and expert perspective

  2026cites this paper
• Impact of circPVT1 Expression on Prostate Cancer Malignancy and Tumor Growth

  2025cites this paper
• Safety and feasibility of “three arms settings” robot-assisted radical prostatectomy using the Hugo RAS system: surgical set-up in a double-center large case series

  2024cites this paper
• Simulation of focal boosting in online adaptive MRI-guided SBRT for patients with locally advanced prostate cancer with seminal vesicle involvement

  2024cites this paper
• Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer

  2023cites this paper
• Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy

  2022cites this paper
• Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy.

  2022cites this paper
• Evaluation of cystoprostatectomy on patients with prostate cancer extending to bladder: a retrospective study from single center

  2022cites this paper
• Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection

  2021cites this paper
• Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting

  2021cites this paper
• The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancer

  2020cites this paper
• The role of surgery in high risk and advanced prostate cancer: A narrative review.

  2020cites this paper
• Surgical management of high-risk, localized prostate cancer

  2020cites this paper
• Salvage treatments for prostate-specific antigen relapse of cT3N0M0 prostatic adenocarcinoma after radical prostatectomy combined with neoadjuvant androgen deprivation

  2020cites this paper
• Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer.

  2019cites this paper
• Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients

  2019cites this paper
• Increased Prostate Cancer Glucose Metabolism Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8-10 Prostate Cancers Identifies Very High-risk Patients for Early Recurrence and Resistance to Castration.

  2019cites this paper
• Journal Pre-proof Primary Radical Prostatectomy or Ablative (RP/EBRT) are Protective Factors in mCRPC Patients Treated With 223Radium-dichloride: An Italian Multicenter Study.

  2019cites this paper
• Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study.

  2019cites this paper
• Identifying the Best Candidate for Radical Prostatectomy in High-Risk Prostate Cancer

  2018cites this paper
• Laparoscopic Radical Prostatectomy in Patients with High-Risk Prostate Cancer: Feasibility and Safety. Results of a Multicentric Study

  2018cites this paper
• Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature.

  2018cites this paper
• Evaluation of clinical staging of the American Joint Committee on Cancer (eighth edition) for prostate cancer

  2018cites this paper
• Radical Prostatectomy for Locally Advanced Prostate Cancers—Review of Literature

  2017cites this paper
• Radical Prostatectomy for High-risk Localized or Node-Positive Prostate Cancer: Removing the Primary

  2017cites this paper
• Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification

  2017cites this paper
• Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study.

  2017cites this paper
• Directions in Diagnosis and Therapy of Prostate Cancer : Controversies in Uro-Oncology

  2017cites this paper
• Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review

  2017cites this paper
• OVERRATING HIGH RISK PROSTATE CANCER ON TRANSRECTAL ULTRASOUND NEEDLE BIOPSY VS RADICAL PROSTATECTOMY SPECIMEN

  2017cites this paper
• Title What is appropriate neoadjuvant / adjuvant androgen deprivation for high-risk / locally advanced prostate cancer ?

  2017cites this paper
• American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer.

  2017cites this paper
• New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.

  2017cites this paper
• Follow-Up After Radical Treatments and Relapse

  2017cites this paper
• Impact of stage migration and practice changes on high‐risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades

  2016cites this paper
• Cancers de la prostate de score de Gleason supérieur ou égal à 8: Evaluation de la survie des patients

  2016cites this paper
• Impact of treatment on progression to castration‐resistance, metastases, and death in men with localized high‐grade prostate cancer

  2016cites this paper
• Is There a Concordance Between the Gleason Scores of Needle Biopsy and Radical Prostatectomy Specimens in Prostatic Carsinoma

  2016cites this paper
• Recent advances in prostate cancer pathology: Gleason grading and beyond

  2016cites this paper
• Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry

  2016cites this paper
• Proposal of Gleason-like grading system of canine prostate carcinoma in veterinary pathology practice.

  2015cites this paper
• Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease.

  2015cites this paper
• Surgical treatment of high-risk prostate cancer.

  2015cites this paper
• Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer.

  2015cites this paper
• Experience with androgen deprivation therapy for prostate cancer in Japan and future perspectives.

  2015cites this paper
• Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer.

  2015cites this paper
• Locally advanced and high risk prostate cancer: The best indication for initial radical prostatectomy?

  2014cites this paper
• Expanding Role of Surgery in Management of High Risk Prostate Cancer

  2014cites this paper
• Percentage of high‐grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score

  2014cites this paper
• The impact of pathologic staging on the long‐term oncologic outcomes of patients with clinically high‐risk prostate cancer

  2014cites this paper
• Is Robot-Assisted Radical Prostatectomy Safe in Men with High-Risk Prostate Cancer? Assessment of Perioperative Outcomes, Positive Surgical Margins, and Use of Additional Cancer Treatments

  2014cites this paper
• Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy.

  2014cites this paper
• Long-term outcome of High-risk Prostate Cancer Treated with Brachytherapy Combined with External-beam Radiation Therapy and Androgen Deprivation Therapy

  2014cites this paper
• The status of surgery in the management of high-risk prostate cancer

  2014cites this paper
• Molecular and Cellular Pathobiology Interleukin-1 b Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features

  2013cites this paper
• Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer

  2013cites this paper
• Current role of surgery for high risk prostate cancer.

  2013cites this paper
• Contemporaneous comparison of open vs minimally‐invasive radical prostatectomy for high‐risk prostate cancer

  2013cites this paper
• Results of surgery for high-risk prostate cancer

  2013cites this paper
• Comparison of positive surgical margin rates in high risk prostate cancer: open versus minimally invasive radical prostatectomy.

  2013cites this paper
• Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.

  2013cites this paper
• Prostate Brachytherapy: Low Dose Rate

  2013cites this paper
• Guidelines on Prostate Cancer

  2013cites this paper
• Factores clínicos y patológicos predictores de recurrencia luego de prostatectomía radical en pacientes con cáncer de próstata de alto riesgo Clinic and pathologic risk factors of recurrence after radical prostatectomy in high-risk prostate cancer patients

  2013cites this paper
• Radical prostatectomy in clinically localized high-risk prostate cancer: Outcome of 231 consecutive patients

  2013cites this paper
• Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer

  2012cites this paper
• High-risk prostate cancer: from definition to contemporary management.

  2012cites this paper
• Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy.

  2012cites this paper
• Usual and Unusual Histologic Patterns of High Gleason Score 8 to 10 Adenocarcinoma of the Prostate in Needle Biopsy Tissue

  2012cites this paper
• Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial

  2012cites this paper
• Preoperative characteristics of high‐Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy

  2012cites this paper
• Association of 5α‐reductase inhibitor use and pathological features of prostate cancer in men undergoing radical prostatectomy

  2012cites this paper
• Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective.

  2012cites this paper
• Robotic radical prostatectomy as the initial step in multimodal therapy for men with high‐risk localised prostate cancer: initial experience of 160 men

  2012cites this paper
• Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious.

  2012influential citation
• Role of hormonal therapy for prostate cancer: perspective from Japanese experiences

  2012cites this paper
• High-Dose-Rate Brachytherapy for the Treatment of Low-, Intermediate-, and High-Risk Prostate Cancer

  2012cites this paper
• Open Radical Prostatectomy

  2012cites this paper
• Prediction of outcomes after radical prostatectomy in patients diagnosed with prostate cancer of biopsy gleason score ≥ 8 via contemporary multi (≥12)‐core prostate biopsy

  2011cites this paper
• Surgery for high-risk localized prostate cancer

  2011cites this paper
• Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer.

  2011cites this paper
• What is appropriate neoadjuvant/adjuvant androgen deprivation for high-risk/locally advanced prostate cancer?

  2011cites this paper
• Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification.

  2011cites this paper
• Pathological results and rates of treatment failure in high‐risk prostate cancer patients after radical prostatectomy

  2011cites this paper
• Long‐term survival after radical prostatectomy versus external‐beam radiotherapy for patients with high‐risk prostate cancer

  2011cites this paper
• Radical Prostatectomy in High-Grade Prostate Cancer, Salvage and Adjuvant Radiotherapy

  2010cites this paper
• Editorial comment.

  2010cites this paper
• Will the Modification of the Gleason Grading System Affect the Urology Practice?

  2010cites this paper
• The effect of modified Gleason grading on the score concordance between the Gleason scores of needle biopsy and radical prostatectomy specimens in prostatic carcinoma

  2010cites this paper
• Treatment strategies for high-risk locally advanced prostate cancer

  2010cites this paper
• Point: Prostate carcinoma treatment for the young patient--the case for brachytherapy.

  2010cites this paper
• Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen.

  2010cites this paper
• Defining and treating high-risk prostate cancer: can we do better?

  2010cites this paper
• Long-Term Survival after Radical Prostatectomy for men with High Gleason Sum in the Pathological Specimen

  2010cites this paper
• Role of surgery in high-risk localized prostate cancer.

  2010cites this paper
• Early oncological outcomes of robot‐assisted radical prostatectomy for high‐grade prostate cancer

  2010cites this paper
• Outcomes for patients with high‐grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy

  2009cites this paper
• Re: Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy.

  2009cites this paper
• Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.

  2009cites this paper
• Management of High-Risk Localised Prostate Cancer

  2009cites this paper